Xarelto® Indications

Sign In

No providers configured, please contact support team.

Practical Management

Prescribing Information

Resources
Country Selection

Practical Management
Responsible Use
Prescriber Aid
Q&A
Bleeding Management

Prescribing Information

Resources
Major Studies
XareltoTUBE
Patient Information

Brazil
Canada
Denmark
France
Germany
Hungary
Japan
Netherlands
Norway
Switzerland
Spain
Sweden
United Kingdom
United States of America

Recent Searches

You Are Now Leaving This Site

Would you like to leave this site?

HomeXarelto® Indications

PP-XAR-ALL-1787-2

Reference

1
Xarelto® (rivaroxaban) Summary of Product Characteristics.